Cargando…
Antidepressant-Warfarin Interaction and Associated Gastrointestinal Bleeding Risk in a Case-Control Study
BACKGROUND: Bleeding is the most common and worrisome adverse effect of warfarin therapy. One of the factors that might increase bleeding risk is initiation of interacting drugs that potentiate warfarin. We sought to evaluate whether initiation of an antidepressant increases the risk of hospitalizat...
Autores principales: | Schelleman, Hedi, Brensinger, Colleen M., Bilker, Warren B., Hennessy, Sean |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3123326/ https://www.ncbi.nlm.nih.gov/pubmed/21731754 http://dx.doi.org/10.1371/journal.pone.0021447 |
Ejemplares similares
-
Thromboembolic and neurologic sequelae of discontinuation of an antihyperlipidemic drug during ongoing warfarin therapy
por: Leonard, Charles E., et al.
Publicado: (2017) -
Correction: Antidepressant-Warfarin Interaction and Associated Gastrointestinal Bleeding Risk in a Case-Control Study
Publicado: (2015) -
Antidepressant drug–drug–drug interactions associated with unintentional traumatic injury: Screening for signals in real‐world data
por: Chen, Cheng, et al.
Publicado: (2022) -
Thromboembolic Events in Users of Warfarin Treated with Different Skeletal Muscle Relaxants
por: Leonard, Charles E., et al.
Publicado: (2022) -
Amphetamines, Atomoxetine and the Risk of Serious Cardiovascular Events in Adults
por: Schelleman, Hedi, et al.
Publicado: (2013)